MACROGENICS INC — Director's Dealing 2016

Jan 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-01-04

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Common Stock	M	10000	$4.70	Acquired	10000	Direct
2016-01-04	Common Stock	S	10000	$29.64	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Employee Stock Option (right to buy)	$4.70	M	10000	Disposed	2023-07-18	Common Stock (10000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: 12.5% of the shares underlying the option became exercisable on January 19, 2014, and 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.

F3: Reflects update to previously filed Form 4 to adjust the remaining grant balance split between incentive stock option (60,194) and non-qualified stock option (60,254) previously reported on Form 3